LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 12 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $34,000 | -99.3% | 18,000 | -99.3% | 0.00% | -100.0% |
| Q1 2017 | $4,603,000 | -16.4% | 2,500,000 | -16.7% | 0.01% | -16.7% |
| Q4 2016 | $5,503,000 | -18.8% | 3,000,000 | 0.0% | 0.01% | -25.0% |
| Q3 2016 | $6,777,000 | +23.7% | 3,000,000 | 0.0% | 0.01% | +33.3% |
| Q2 2016 | $5,477,000 | +10.4% | 3,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $4,960,000 | -5.5% | 3,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $5,246,000 | – | 3,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 5,250,000 | $4,410,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,000,000 | $5,475,000 | 0.04% |
| MACKAY SHIELDS LLC | 30,000 | $26,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 320,000 | $252,000 | 0.00% |